Alberta Investment Management Corp I Mab Transaction History
Alberta Investment Management Corp
- $13.3 Billion
- Q4 2024
A detailed history of Alberta Investment Management Corp transactions in I Mab stock. As of the latest transaction made, Alberta Investment Management Corp holds 74,723 shares of IMAB stock, worth $73,228. This represents 0.0% of its overall portfolio holdings.
Number of Shares
74,723
Previous 74,723
-0.0%
Holding current value
$73,228
Previous $92,000
31.52%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding IMAB
# of Institutions
38Shares Held
16MCall Options Held
56.4KPut Options Held
5.8K-
Hhlr Advisors, Ltd. Grand Cayman, E96.91MShares$6.77 Million0.2% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC4.17MShares$4.08 Million3.04% of portfolio
-
Boothbay Fund Management, LLC New York, NY1.42MShares$1.39 Million0.05% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U0567KShares$555,3170.0% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny499KShares$489,3140.0% of portfolio
About I-Mab
- Ticker IMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,098,800
- Market Cap $81.4M
- Description
- I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...